Work

A phase 1 trial of the oncolytic virus SVV-001 with nivolumab and ipilimumab in patients with high-grade neuroendocrine neoplasms.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.tps2700

Authors: Chinmay Jani, Isildinha M. Reis, Rakhi Modak, Daniel Bilbao Cortes, Stephanie Baboun, Alexander Rivera, Hung Trinh, Paul L. Hallenbeck, Dionysios C. Watson, Samuel A. Kareff, Jaime R. Merchan, Gilberto Lopes, Peter Joel Hosein, Aman Chauhan

Institutions: University of Miami, Sylvester Comprehensive Cancer Center, Jackson Memorial Hospital

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162680995

Cites:

Cited by:

Related to: